Filing Details

Accession Number:
0001104659-19-005835
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-05 16:19:45
Reporting Period:
2019-02-05
Accepted Time:
2019-02-05 16:19:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1509745 Leap Therapeutics Inc. LPTX () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1490245 Healthcare Ventures Ix, L.p. C/o Leap Therapeutics, Inc.
47 Thorndike Street Suite B1-1
Cambridge MA 02141
No No Yes No
1697027 Healthcare Partners Ix, L.p. C/o Leap Therapeutics, Inc.
47 Thorndike Street Suite B1-1
Cambridge MA 02141
No No Yes No
1698828 Healthcare Partners Ix, Llc C/o Leap Therapeutics, Inc.
47 Thorndike Street Suite B1-1
Cambridge MA 02141
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-02-05 571,428 $1.75 4,144,804 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, $0.001 Par Value Per Share Warrant (Right to Buy) Acquisiton 2019-02-05 571,428 $0.00 571,428 $1.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
571,428 2019-02-05 2026-02-05 No 4 P Direct
Footnotes
  1. The shares are owned directly by HealthCare Ventures IX, L.P. Christopher K. Mirabelli, Douglas E. Onsi and Augustine Lawlor (collectively, the "HCVIX Directors") are the Managing Directors of HealthCare Partners IX, LLC ("HCPIX LLC"), which is the General Partner of HealthCare Partners IX, L.P. ("HCPIX"), which is the General Partner of HealthCare Ventures IX, L.P. Each of the HCVIX Directors, HCPIX LLC and HCPIX indirectly beneficially own and share voting and dispositive power with respect to all of the securities owned by HealthCare Ventures IX, L.P. and each disclaims beneficial ownership of these shares except to the extent of his or its proportionate pecuniary interest in these securities.
  2. The reported securities were included with the 571,428 shares of common stock purchased by the reporting persons for $1.75 per share. Each such purchased share of common stock was issued with a warrant to purchase one share of common stock.